[go: up one dir, main page]

AR012109A1 - Derivados de bencenosulfonamida, su preparacion, su aplicacion en terapeutica y composicion farmaceutica - Google Patents

Derivados de bencenosulfonamida, su preparacion, su aplicacion en terapeutica y composicion farmaceutica

Info

Publication number
AR012109A1
AR012109A1 ARP980101236A ARP980101236A AR012109A1 AR 012109 A1 AR012109 A1 AR 012109A1 AR P980101236 A ARP980101236 A AR P980101236A AR P980101236 A ARP980101236 A AR P980101236A AR 012109 A1 AR012109 A1 AR 012109A1
Authority
AR
Argentina
Prior art keywords
group
benzenosulfonamide
therapeutics
derivatives
preparation
Prior art date
Application number
ARP980101236A
Other languages
English (en)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of AR012109A1 publication Critical patent/AR012109A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compuesto de la formula (I) en la cual: A representa un átomo de hidrogeno, un halogeno tal como el fluor, el coloro o el bromo, un grupo ciano, un grupoC1-4 alquilo o un grupo alcoxi; R1 y R2 idénticos o diferentes, repesentan cada uno un átomo de hidrogeno, un grupo C1-C6 alquilo, un grupo C2-6 alquenilo o R1y R2 forman juntos una cadena C2-6 alquileno o C2-6 alquenileno y R3 representa un átomo de hidrogeno o un grupo C1-4 alquilo con la exclusion del clorhidratode 3-bencenosulfonamidoguanidina. Aplicacion en terapéutica.
ARP980101236A 1997-03-20 1998-03-19 Derivados de bencenosulfonamida, su preparacion, su aplicacion en terapeutica y composicion farmaceutica AR012109A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9703394A FR2761061B1 (fr) 1997-03-20 1997-03-20 Derives de benzenesulfonamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR012109A1 true AR012109A1 (es) 2000-09-27

Family

ID=9505005

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101236A AR012109A1 (es) 1997-03-20 1998-03-19 Derivados de bencenosulfonamida, su preparacion, su aplicacion en terapeutica y composicion farmaceutica

Country Status (6)

Country Link
EP (1) EP0971900A1 (es)
AR (1) AR012109A1 (es)
AU (1) AU6924198A (es)
FR (1) FR2761061B1 (es)
WO (1) WO1998042679A1 (es)
ZA (1) ZA982358B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ331480A (en) * 1997-09-04 2000-02-28 F 2-(Arylphenyl)amino-imidazoline derivatives and pharmaceutical compositions
US6323231B1 (en) 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence
DE10106214A1 (de) * 2001-02-10 2002-08-14 Boehringer Ingelheim Pharma Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2456731A1 (fr) * 1979-05-16 1980-12-12 Choay Sa Nouveaux derives substitues d'ary
FR2549049B1 (fr) * 1983-07-13 1986-06-20 Chauvin Blache Lab Nouvelles amidines, leur procede de preparation et leur application therapeutique
US4788195A (en) * 1986-01-13 1988-11-29 American Cyanamid Company 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
ZA982358B (en) 1998-09-22
WO1998042679A1 (fr) 1998-10-01
EP0971900A1 (fr) 2000-01-19
FR2761061A1 (fr) 1998-09-25
FR2761061B1 (fr) 1999-04-23
AU6924198A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
PE20030188A1 (es) Compuesto de anillo fundido como inhibidores de polimerasa del virus de la hepatitis c
AR021534A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonano, su preparacion y su aplicacion en terapeutica
AR021533A1 (es) Derivados de 2,5-diazabiciclo[2.2.1]heptano, su preparacion y su aplicacion en terapeutica
AR025276A1 (es) El uso de un compuesto que es un derivado de 2-amino-1,3-tiazol, un compuesto que es un derivado de 2-amino-1,3-tiazol, un procedimiento para producirlo y una composicion farmaceutica que lo comprende
PE20070018A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasas
ATE302775T1 (de) Carbolinderivate
UY26439A1 (es) Nueva composición y uso
PE20040684A1 (es) Derivados de bencimidazol como antagonistas de histamina h3
HUP0202263A2 (hu) Benzimidazol-, indol- és imidazo-piridin-származékok és ezeket tartalmazó gyógyszerkészítmények
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
AR023681A1 (es) Derivados de tetrahidrobenzazepinas, composiciones farmaceuticas y el uso de los mismos para la manufactura de un medicamento.
CO5611143A2 (es) Profarmacos de fosfatos de fluorooxindoles
ATE346067T1 (de) Carbolinderivate
DK1421075T3 (da) Piperidinderivater, der er nyttige som CCR5-antagonister til behandling af HIV
AR027296A1 (es) Derivados de 4-heteroaril-1,4-diazabiciclo[3.2.2]nonano, su preparacion y su aplicacion terapeutica
CO5601021A2 (es) Derivados de quinazolinona, composiciones farmaceuticas que los contienen y su proceso de preparacion y su uso como antagonistas cb
ATE359791T1 (de) Pyrimidin-2,4-dion-derivate als matrix- metalloproteinase-hemmer
AR013503A1 (es) Una combinacion de un inhibidor de la monoamina oxidasa y un antagonista o agonista parcial selectivo de h5-ht(1b), formulacion farmaceutica, usos ymetodo de preparacion
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
EA200200831A1 (ru) Фармацевтическая композиция, включающая пеметрексед вместе с монотиоглицерином, l-цистеином или тиогликолевой кислотой
SE9901077D0 (sv) Novel use
AR028647A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonano benzoxazol, benzotiazol y bencimidazol, su preparacion y su aplicacion en terapéutica
EP1379508A4 (en) N- (ARYL) -2-ARYLETHESULFONAMIDES AND THEIR THERAPEUTIC APPLICATIONS
AR054524A1 (es) Metodos y formas de dosificacion para reducir los efectos secundarios de compuestos de carbamato
NO20014855L (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister